Skip to main content
The Global Fund / Le Fonds mondial
Country Resources
Applying for Funding (GC8)
Search
Français
Search
Home
About Us
▶
About the Global Fund
Staff & Organization
Strategy & Framework
▶
Strategy (2023-2028)
The Global Fund's Monitoring and Evaluation Framework
Structures & Governance
▶
Governance & Policies
Board
Country Coordinating Mechanisms
Independent Evaluation & Learning
Local Fund Agents
Office of the Inspector General
Technical Review Panel
Our Partnership
▶
Civil Society
Friends of the Fund
Government & Public Donors
Implementing Partners
Private Sector & Philanthropy
Technical & Development Partners
Topics
▶
Diseases
HIV/AIDS
Tuberculosis
Malaria
Health Systems
Resilient & Sustainable Systems for Health
Antimicrobial Resistance
Community Health Workers
Digital Health
Laboratory Systems Strengthening
Community Responses & Systems
Cross-cutting
Children
Health and Climate
Human Rights
Gender Equality
Global Health Security
Key Populations
Protection from Sexual Exploitation, Abuse and Harassment
Funding & Replenishment
▶
Funding & Finance
▶
How We Fund Our Grants
Who We Fund
Sustainability, Transition & Co-Financing
Resource Mobilization & Replenishment
▶
How We Raise Funds
Innovative Finance
Blended Financing
Debt Swaps (Debt2Health)
What is Replenishment
Eighth Replenishment
News & Media
▶
Latest
News Releases
Updates
Opinion
Stories
For Press
Newsroom
Digital Media Library
Multimedia
Video
Photo Galleries
Publications & Results
▶
Reports
Results Report
Donor Reports
Impact Reports
Thematic Reports
Partnership Reports
Other
Overviews
Resources & Data
▶
Data & Tools
Data Explorer
Data Service
Subsites
Country Resources
Sourcing & Management of Health Products
Contact & Engagement
▶
Work with us
Business & Consultancy Opportunities
Careers
Join us
Events
Contact Us
Lenacapavir
Home
Related Links
Lenacapavir
Print
Link copied!
Facebook
X
LinkedIn
Markdown version of the page
7 items since 2024
Often appears with
HIV and AIDS
Innovation
United States
News
3
items
News
24 September 2026
Global Fund Prepares for Major Expansion in Access to Lenacapavir as Generic Supply Approaches
News
09 July 2025
Global Fund Secures Access to Breakthrough HIV Prevention Drug Lenacapavir for Low- and Middle-Income Countries
News
17 December 2024
Global Fund, PEPFAR Announce Coordinated Effort to Reach 2 Million People with Lenacapavir for PrEP to Significantly Reduce Global HIV Infections
Update
2
items
Update
14 April 2026
Global Fund and U.S. Expand Commitment to Long-Acting HIV Prevention as Country Rollout of Lenacapavir Accelerates
Update
04 September 2025
The Global Fund Welcomes Commitment by the United States to Expand Access to Lenacapavir
Story
1
item
Story
08 April 2026
In Eswatini, an HIV Breakthrough Delivered
Other
1
item
07 April 2026
Opportunity for Evaluation of Finished Pharmaceutical Products Lenacapavir for Pre-Exposure Prophylaxis
